Last reviewed · How we verify

Coly-Mycin S (tonzonium)

Par Sterile Products · FDA-approved active Quality 35/100

Coly-Mycin S (generic name: tonzonium) is a tonzonium drug developed by Par Sterile Products. It is currently FDA-approved (first approved 1962) for Mastoidectomy Cavity Infections, Otitis externa.

At a glance

Generic nametonzonium
SponsorPar Sterile Products
Drug classtonzonium
TargetInsulin-degrading enzyme
Therapeutic areaMetabolic
PhaseFDA-approved
First approval1962

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Coly-Mycin S

What is Coly-Mycin S?

Coly-Mycin S (tonzonium) is a tonzonium drug developed by Par Sterile Products, indicated for Mastoidectomy Cavity Infections, Otitis externa.

What is Coly-Mycin S used for?

Coly-Mycin S is indicated for Mastoidectomy Cavity Infections, Otitis externa.

Who makes Coly-Mycin S?

Coly-Mycin S is developed and marketed by Par Sterile Products (see full Par Sterile Products pipeline at /company/par-sterile-products).

What is the generic name of Coly-Mycin S?

tonzonium is the generic (nonproprietary) name of Coly-Mycin S.

What drug class is Coly-Mycin S in?

Coly-Mycin S belongs to the tonzonium class. See all tonzonium drugs at /class/tonzonium.

When was Coly-Mycin S approved?

Coly-Mycin S was first approved on 1962.

What development phase is Coly-Mycin S in?

Coly-Mycin S is FDA-approved (marketed).

What does Coly-Mycin S target?

Coly-Mycin S targets Insulin-degrading enzyme and is a tonzonium.

Related